Introduction
Thrombopoietin (Tpo) is critical for the maintenance of hematopoietic stem and progenitor cells and is also the primary regulator of megakaryocyte development 1;2 . The binding of Tpo to its receptor, c-Mpl, causes associated Janus kinase 2 (Jak2) activation, which in turn phosphorylates (activates) several downstream effectors including signal transducers and activators of transcription (STAT) 3 and 5, mitogen-activated protein kinase (MAPK), phosphotidylinositol-3-kinase (PI3-K) and protein kinase C (PKC) [3] [4] [5] [6] [7] . Activation of these pathways promotes proliferation and survival in c-Mpl-expressing cell lines and hematopoietic progenitor cells, in addition to megakaryocyte lineage differentiation and maturation [8] [9] [10] [11] . It is critical that Tpo signal transduction is stringently controlled to prevent uncontrolled proliferation. Suppressors of cytokine signaling (SOCS) proteins, phosphatases and negative regulators such FAK, Lnk and Lyn have all been shown to down-modulate Tpo-induced signaling [12] [13] [14] [15] . However, the most effective method of regulating Tpo signaling is by controlling expression of c-Mpl on the plasma membrane. Tpo-mediated c-Mpl endocytosis, recycling and degradation are rapid mechanisms to control signaling longevity and represent a mechanism by which Tpo signaling can be regulated without new protein expression.
The principal mechanism of receptor mediated endocytosis in eukaryotic cells is the clathrin-coated vesicle 16 . Soluble clathrin molecules self-assemble and are recruited to the plasma membrane where they form lattice structures and interact with transmembrane receptors via adaptor proteins (AP), such as AP2, to form clathrin-coated pits 17;18 . These pits then further invaginate before finally budding from the membrane to form clathrin-coated vesicles. AP2 is a heterotetramer composed of α2, β2, µ2 and σ2 subunits. The α2 and β2 subunits localize AP2 to the membrane, recruit endocytic accessory proteins and bind clathrin heavy chain [19] [20] [21] .
Transmembrane proteins are associated with the AP2-clathrin complex via the µ2 domain, which binds directly to cytoplasmic YXXΦ (where X=any amino acid and Φ =bulky hydrophobic residue) and [DE] XXXL[IL] motifs 22;23 . To ensure that AP2 specifically associates with membrane-bound proteins, phosphorylation of 156 Thr in the µ2 subunit results in a conformational change in AP2, dramatically increasing the affinity of µ2 for YXXΦ motifs 24;25 . 156 Thr is phosphorylated by adaptor-associated kinase 1 (AAK1) 26 , the activity of which is maximized by its association with clathrin 27;28 , ensuring that AP2-cargo protein interactions are initiated only at the plasma membrane. In addition to being an endocytic signal, YXXΦ motifs 
Materials and Methods

Chemicals and Reagents
Pharmacological inhibitors JakI, LY294002, SU6656 and U0126 where all purchased from Calbiochem (San Diego, CA.). The clathrin inhibitor monodansylcadaverine (MDC), the proteosome inhibitor Z-LLL-al (ZL) and cycloheximide were purchased from Sigma (St. Louis, MO.). Extracellular-specific polyclonal rabbit anti-human c-Mpl was provided by Amgen Pharmaceuticals (Thousand Oaks, CA.) and intracellular-specific polyclonal rabbit anti-human cMpl was purchased from Upstate (Lake Placid, NY.). Monoclonal mouse anti-AP2α2 antibody
For personal use only. on June 11, 2017 . by guest www.bloodjournal.org From was purchased from BD Biosciences (La Jolla, CA.). Antibodies specific to phospho-specific and total Jak2, STAT5, AKT and ERK1/2 were purchased from Cell Signaling Technologies (Danvers, MA.) Monoclonal mouse anti-actin was purchased from Sigma. Secondary antibodies, goat anti-rabbit-horseradish peroxidase (HRP) and rabbit anti-mouse-HRP were purchased from Santa Cruz Biotechnology (Santa Cruz, CA.) and fluorescently labeled goat antirabbit-488 was purchased from Invitrogen (Carlsbad, CA.). Membrane-impermeable sulfo-NHS-biotin and Neutravidin-coupled agarose beads were purchased from Pierce (Rockford, IL.).
Recombinant human (rh) Tpo was a gift from Don Foster, Zymogenetics (Seattle, WA).
Plasmid Construction
Wildtype human c-Mpl (NM_005373.1) was cloned into the retroviral expression vector pMX- 
Cell Lines and Culture Conditions
The interleukin-3 (IL-3)-dependent prolymphoid cell line BaF3 and BaF3-Mpl clones were maintained in RPMI1640 medium containing 10% fetal bovine serum (FBS) supplemented with IL-3 (2µl/ml conditioned medium from IL-3-producing baby hamster kidney cells). The retroviral packaging cell line Platinum-E (Plat-E) were maintained in Dulbecco's modified 
RNA Interference
The previously described AP2α2 subunit siRNA target sequence AAGAGCAUGUGCACGCUGGCCA 35 and the DY547-labeled negative control were purchased from Dharmacon (Chicago, IL.). BaF3-Mpl cells were transfected using an Amaxa nucleofector (Gaithersburg, MD.) according to the manufacturer's protocol. Briefly, 4x10 
Internalization Assays
BaF3-Mpl clones were starved of IL-3 for 2 hr before stimulation with 50ng/ml rhTpo for 0, 10, 30 and 60 min. Cells were washed 3 times in cold phosphate buffered saline (PBS) before biotinylation of the extracellular domains of membrane-bound proteins with 5mg/ml sulfo-NHSbiotin for 30 min at 4˚C, a cell impermeable biotinylation reagent. Further protein biotinylation was prevented by washing the cells 3 times with cold PBS containing 100mM glycine. Cells were lysed in NP-40 buffer and protein concentrations determined using the BCA protein assay kit (Pierce). Biotinylated proteins were pulled down using Neutravidin-conjugated agarose beads, proteins denatured by adding NaDodSO 4 -loading dye and boiling for 5 min and c-Mpl expression analyzed by western blotting.
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MTT Proliferation Assay
BaF3-Mpl clones in log-phase growth were washed 3 times with PBS to remove IL-3, resuspended in RPMI 1640 supplemented with 2% FBS and plated into 96-well plates at a concentration of 1000 cells / well before rhTpo was added at concentrations ranging from 1pg/ml to 10ng/ml. Cells were incubated for 48 hr before treatment with 1mg/ml 3- (4, 1A ). These kinetics are comparable to those previously published 34 . To determine whether c-Mpl internalization was dependent on clathrin-mediated endocytosis cells were pre-treated with an inhibitor of clathrin-coated pit formation, MDC 36 .
Results
Tpo-induced internalization of c-Mpl is mediated by Jak and Src Family
MDC addition inhibited c-Mpl internalization in a concentration-dependent manner with maximal attenuation
For personal use only. on June 11, 2017 . by guest www.bloodjournal.org From achieved at 500µM (Fig. 1B) , indicating that Tpo-induced receptor internalization is dependent on the formation of clathrin-coated pits. To further determine the intracellular signaling mechanisms responsible for c-Mpl internalization, we used pharmacological inhibitors to several kinases activated by Tpo, including Jak2, SFKs, phosphoinositol 3-kinase (PI3K) and extracellular stimulus response kinase (ERK)1/2. Inhibitors to Jak2 and SFKs (JAK I and SU6656 respectively) greatly reduced Tpo-stimulated c-Mpl internalization, whilst inhibitors to PI3K and ERK1/2 had no effect (Fig. 1C) . A concentration-dependent inhibition of c-Mpl internalization by pre-incubation with JAK I and SU6656 was further demonstrated (Fig. 1D and E).
AP2 is essential for Mpl internalization
To determine whether AP2 is required for Tpo-induced c-Mpl internalization, BaF3-Mpl cells were transfected with siRNA specific to the α2 subunit of AP2. Western blot analysis of whole cell lysates after treatment with siRNA demonstrated an approximate 4-fold decrease in AP2α2 protein expression after 48 hr ( Fig. 2A) . For internalization studies, BaF3-Mpl cells were transfected with AP2α2 siRNA for 48 hr prior to stimulation with 50ng/ml Tpo, before cMpl expression was analyzed by flow cytometry. AP2α2-depleted cells exhibited greatly reduced c-Mpl internalization in response to Tpo; c-Mpl expression was reduced to 55.3% [± 9.6] of baseline expression in control cultures whereas AP2α2 siRNA-treated cell c-Mpl expression was reduced only to 91.2% (±1.9) of baseline maximal expression (Fig. 2B) .
c-Mpl internalization is mediated via an AP2-Y 78 RRL motif interaction
The AP2µ2 domain has previously been shown to interact with YXXΦ motifs on transmembrane receptors and drive clathrin-mediated receptor endocytosis 22 (Fig. 3A) . In the absence of Tpo, there was no significant difference in cell surface expression of c-Mpl between clones when analyzed by flow cytometry (data not shown).
Using a membrane impermeable biotinylation reagent and a streptavidin pull-down strategy we were able to accurately determine expression of c-Mpl on the cell surface following
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Tpo stimulation in the BaF3-Mpl wildtype and mutant clones. Previous findings suggest that post-translational modifications of c-Mpl give rise to a more "mature" form of the receptor, which is expressed at the cell membrane 37 . In accordance with this finding western blot analyses of human c-Mpl -bearing cell lines display two specific protein bands, one migrating at 80kDa
and a second at 85kDa, the latter of which represents the mature cell surface form of the c-Mpl receptor (Fig 3B) . We measured the intensity of the 85kDa band to evaluate Tpo-induced Mpl internalization in the BaF3-Mpl clones. Cells were stimulated with 50ng/ml rhTpo for 10, 30
and 60 min prior to membrane biotinylation, lysis and streptavidin pull-down. Levels of internalization were quantified by densitometry of the 85kDa membrane-localized c-Mpl band in Interestingly, we found that signaling was not affected by knocking down AP2α2 protein expression (Fig. 4C ), even to levels that blunted c-Mpl Y 78 F receptor internalization, suggesting that attenuating receptor internalization may not significantly affect Tpo signaling in these cells.
c-Mpl lysosome targeting is mediated by the Y 8 RRL motif
It has previously been demonstrated that YXXΦ motifs localized between 6-9 residues from the transmembrane domain mediate lysosomal targeting of internalized receptors 31;32 . Consequently, we assessed whether the c-Mpl Y 8 RRL motif was involved in targeting the internalized receptor for lysosomal degradation. To accurately determine the effects on receptor degradation we treated BaF-Mpl cells with the protein synthesis inhibitor cycloheximide (1µg/ml) for a range of time periods from 0 to 120 min; c-Mpl expression was then analyzed by western blot and the ratio of 80kDa ("immature") to 85kDa ("mature") Mpl determined by densitometry (Fig. 5A ). In the absence of cycloheximide, the majority (~80%) of Mpl exists as an 80kDa form. In the presence of cycloheximide, the mature form (85kDa) becomes increasingly predominant with time. In the subsequent experiments cells were treated with cycloheximide for 60 min, having determined that after this period of treatment synthesis of new protein had been prevented without significant cell death (data not shown). Cycloheximidetreated cells were stimulated with rhTpo (50ng/ml) for 0 to 120 min before the level of c-Mpl degradation was determined by western blot analysis and densitometry. In wildtype c-Mplexpressing cells Tpo-stimulation resulted in a steady degradation of the receptor (Fig. 5B) Regulation of AP2 localization and binding is mediated by phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) 40 and AAK-1 kinase activity 26;27 . PI(4,5)P2 interacts via two binding sites on AP2, one on the α-subunit to dock the complex at the plasma membrane 19 and the other on the µ-subunit
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. AAK-1 increases the affinity of the µ-subunit to bind its target cargo by phosphorylation of 156 Thr. We have shown that Tpo is able to directly cause the internalization of its receptor via activation of Jak2 and SFKs signaling cascades, although the downstream effectors remain unclear. Interestingly, a previous finding that c-Mpl Y 112 mediates receptor internalization 34 could also support a potential role for SFKs in regulating c-Mpl endocytosis as this residue has previously been shown to regulate Tpo-stimulated Lyn kinase activity 42 . The role of SFKs in regulating receptor internalization has been studied previously with differing results. For example, the SFK inhibitor SU6656 fails to attenuate internalization of epidermal growth factor receptor (EGFR) 43 , but previous studies on the stem cell factor receptor c-Kit, suggest that SFKs are vital for internalization and degradation of the receptor 44;45 . We have For personal use only. on June 11, 2017 . by guest www.bloodjournal.org From
